U.S. stock indexes ended the week lower, with the S&P 500 falling 0.6% and the Nasdaq dropping 2.1% for their second consecutive weekly losses. Oil prices surged more than 8% for WTI crude and nearly 10% for international Brent, temporarily breaking above $100 per barrel amid fears of escalation in the Iran conflict, reigniting inflation concerns and boosting expectations for a potential Federal Reserve rate hike. Alphabet shares fell 7% after revealing capital expenditures of $195 billion to $205 billion this year, reflecting growing market skepticism about returns on massive AI investments. In healthcare, Eli Lilly rose 2% on positive late-stage data for its experimental obesity drug retatrutide, while Johnson & Johnson gained 4.1% after the FDA unexpectedly approved its Ottava robotic surgery system.
Source: Read the original article
